Zlotnik A, Roberts W K, Vasil A, Blumenthal E, Larosa F, Leibson H J, Endres R O, Graham S D, White J, Hill J, Henson P, Klein J R, Bevan M J, Marrack P, Kappler J W
J Immunol. 1983 Aug;131(2):794-800.
The T cell hybridoma FS7-20, produced by the fusion of normal B10.BR T cells to the AKR thymoma BW5147, was found when stimulated with concanavalin A (Con A) to produce the lymphokines: interleukin 2 (IL 2), interferon-gamma (IFN gamma), macrophage-activating factor (MAF), Ia induction factor IaIF), and the B cell helper factor interleukin X (IL X). The clones and subclones of FS7-20 varied dramatically in their ability to produce these lymphokines, presumably because of karyotypic variations. The ability to produce IL 2 segregated independently from the ability to produce the four other lymphokine activities; however, production of the latter activities showed a strong correlation. This coordinate production of IFN gamma, MAF, IaIF, and IL X was also observed with a cloned normal cytotoxic T cell line, cr15. These results suggest either that IFN gamma, MAF, IaIF, and IL X are all manifestations of a single molecular species or that, although these activities are different structurally, their production is controlled by a common genetic mechanism. In support of the first possibility, the IFN gamma, MAF, IaIF, and IL X activity produced by FS7-20 were all found to be equally sensitive to inactivation at pH 2. These results illustrate the usefulness of using T cell hybridomas for the study of lymphokines.
由正常B10.BR T细胞与AKR胸腺瘤BW5147融合产生的T细胞杂交瘤FS7-20,在用刀豆球蛋白A(Con A)刺激时,被发现能产生淋巴因子:白细胞介素2(IL 2)、干扰素-γ(IFNγ)、巨噬细胞激活因子(MAF)、Ia诱导因子(IaIF)以及B细胞辅助因子白细胞介素X(IL X)。FS7-20的克隆和亚克隆产生这些淋巴因子的能力差异很大,推测是由于核型变异。产生IL 2的能力与产生其他四种淋巴因子活性的能力独立分离;然而,后几种活性的产生显示出很强的相关性。在克隆的正常细胞毒性T细胞系cr15中也观察到了IFNγ、MAF、IaIF和IL X的这种协同产生。这些结果表明,要么IFNγ、MAF、IaIF和IL X都是单一分子种类的表现形式,要么尽管这些活性在结构上不同,但它们的产生受共同的遗传机制控制。支持第一种可能性的是,发现FS7-20产生的IFNγ、MAF、IaIF和IL X活性在pH 2时对失活同样敏感。这些结果说明了使用T细胞杂交瘤研究淋巴因子的有用性。